Outcomes with Immunochemotherapy Plus Radiation Versus Immunochemotherapy Alone in Stage I Diffuse Large B-Cell Lymphoma: A Retrospective Study

被引：0
|
作者：
Ng, Wern Lynn [1 ]
Bock, Allison M. [2 ]
Kovalenko, Iuliia [1 ]
Wert, Yijin [1 ]
Ng, Lay She [3 ]
Wang, Yucai [4 ]
Nowakowski, Grzegorz S. [4 ]
机构：
[1] UPMC Harrisburg, Harrisburg, PA USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Royal Coll Surg Ireland & Univ Coll Dublin Malays, George Town, Malaysia
[4] Mayo Clin, Div Hematol, Dept Med, Rochester, MN USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-171148
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3829 / 3830
页数：2
相关论文
共 50 条
  • [41] Pharmacodynamics of Rivaroxaban and Dabigatran in Adults with Diffuse Large B-Cell Lymphoma Receiving R-CHOP Immunochemotherapy
    Punnachet, Teerachat
    Cressey, Tim R.
    Apiwatnakorn, Porntipa
    Koonarat, Atisa
    Norasetthada, Lalita
    Tantiworawit, Adisak
    Rattarittamrong, Ekarat
    Rattanathammethee, Thanawat
    Hantrakool, Sasinee
    Piriyakhuntorn, Pokpong
    Hantrakun, Nonthakorn
    Niprapan, Piangrawee
    Chai-Adisaksopha, Chatree
    PHARMACEUTICS, 2024, 16 (10)
  • [42] Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
    Ghesquieres, Herve
    Slager, Susan L.
    Jardin, Fabrice
    Veron, Amelie S.
    Asmann, Yan W.
    Maurer, Matthew J.
    Fest, Thierry
    Habermann, Thomas M.
    Bene, Marie C.
    Novak, Anne J.
    Mareschal, Sylvain
    Haioun, Corinne
    Lamy, Thierry
    Ansell, Stephen M.
    Tilly, Herve
    Witzig, Thomas E.
    Weiner, George J.
    Feldman, Andrew L.
    Dogan, Ahmet
    Cunningham, Julie M.
    Olswold, Curtis L.
    Molina, Thierry Jo
    Link, Brian K.
    Milpied, Noel
    Cox, David G.
    Salles, Gilles A.
    Cerhan, James R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (33) : 3930 - +
  • [43] Survival of very elderly patients with diffuse large B-cell lymphoma according to treatment intensity in the immunochemotherapy era: a Swedish Lymphoma Register study
    Sonnevi, Kristina
    Wasterlid, Tove
    Melen, Christopher M.
    Harrysson, Sara
    Smedby, Karin E.
    Wahlin, Bjorn E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (01) : 75 - 81
  • [44] Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study
    De Sanctis, Vitaliana
    Di Rocco, Alice
    Cox, Maria Christina
    Valeriani, Maurizio
    Congedi, Francesca Perrone
    Anzellini, Dimitri
    Massaro, Maria
    Vullo, Gianluca
    Facondo, Giuseppe
    De Giacomo, Flavia
    Alfo, Marco
    Prosperi, Daniela
    Pizzichini, Patrizia
    Pelliccia, Sabrina
    Tafuri, Agostino
    Martelli, Maurizio
    Osti, Mattia Falchetto
    IN VIVO, 2020, 34 (03): : 1407 - 1413
  • [45] Sequential development of peripheral t-cell lymphoma post immunochemotherapy of diffuse large B cell lymphoma
    Wang, Jing-Wen
    Chen, Jia-Yan
    Lu, Chen
    Tang, Xi
    CANCER BIOLOGY & THERAPY, 2017, 18 (04) : 201 - 202
  • [46] CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
    Rydstrom, Karin
    Linderoth, Johan
    Nyman, Heidi
    Ehinger, Mats
    Joost, Patrick
    Bendahl, Par-Ola
    Leppa, Sirpa
    Jerkeman, Mats
    LEUKEMIA & LYMPHOMA, 2010, 51 (09) : 1643 - 1648
  • [47] Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy
    Nyman, Heidi
    Adde, Magdalena
    Karjalainen-Lindsberg, Marja-Liisa
    Taskinen, Minna
    Berglund, Mattias
    Amini, Rose-Marie
    Blomqvist, Carl
    Enblad, Gunilla
    Leppa, Sirpa
    BLOOD, 2007, 109 (11) : 4930 - 4935
  • [48] Conservative management with radiotherapy and immunochemotherapy in primary diffuse large B-cell lymphoma of the cervix: Diagnosis and treatment of a rare entity
    Robles Diaz, J. F.
    CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA, 2023, 50 (03):
  • [49] Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma
    Chen, Wanjun
    Liang, Weijie
    He, Yongjian
    Liu, Chixiang
    Chen, Hongtian
    Lv, Piao
    Yao, Yuan
    Zhou, Huayou
    MEDICAL ONCOLOGY, 2022, 39 (04)
  • [50] CD5 is an unfavorable prognostic factor in diffuse large B-cell lymphoma (DLBCL) patients treated with immunochemotherapy
    Cemerikic-Martinovic, V.
    Drndarevic, N.
    Jovanovic, D.
    Martinovic, T.
    Markovic, O.
    Marisavljevic, D.
    VIRCHOWS ARCHIV, 2011, 459 : S100 - S100
12345